Alkem Launches Pertuzumab Biosimilar In India

Rival To Perjeta ‘Meets Global Standards’, Firm Emphasizes

 
• By Dave Wallace
  
Alkem has launched a pertuzumab biosimilar in India (Shutterstock)

More from Biosimilars

More from Products